Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a two-component acellular pertussis vaccine in infants.
Liese JG, Meschievitz CK, Harzer E, Froeschle J, Hosbach P, Hoppe JE, Porter F, Stojanov S, Niinivaara K, Walker AM, Belohradsky BH. Liese JG, et al. Among authors: stojanov s. Pediatr Infect Dis J. 1997 Nov;16(11):1038-44. doi: 10.1097/00006454-199711000-00007. Pediatr Infect Dis J. 1997. PMID: 9384336
Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group.
Stojanov S, Liese JG, Bendjenana H, Harzer E, Barrand M, Jow S, Dupuy M, Belohradsky BH. Stojanov S, et al. Pediatr Infect Dis J. 2000 Jun;19(6):516-21. doi: 10.1097/00006454-200006000-00005. Pediatr Infect Dis J. 2000. PMID: 10877165 Clinical Trial.
Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group.
Liese JG, Stojanov S, Zink TH, Froeschle J, Klepadlo R, Kronwitter A, Harzer E, Jow S, Belohradsky BH. Liese JG, et al. Among authors: stojanov s. Pediatr Infect Dis J. 2001 Oct;20(10):981-8. doi: 10.1097/00006454-200110000-00012. Pediatr Infect Dis J. 2001. PMID: 11642633
Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine.
Stojanov S, Liese JG, Belohradsky BH, Vandermeulen C, Hoppenbrouwers K, Van der Wielen M, Van Damme P, Georges B, Dupuy M, Scemama M, Watson M, Fiquet A, Stek JE, Golm GT, Schödel FP, Kuter BJ; HEXAVAC/VAQTA Study Group. Stojanov S, et al. Vaccine. 2007 Oct 23;25(43):7549-58. doi: 10.1016/j.vaccine.2007.08.028. Epub 2007 Sep 4. Vaccine. 2007. PMID: 17905486 Clinical Trial.
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.
Mallet E, Belohradsky BH, Lagos R, Gothefors L, Camier P, Carrière JP, Kanra G, Hoffenbach A, Langue J, Undreiner F, Roussel F, Reinert P, Flodmark CE, Stojanov S, Liese J, Levine MM, Muñoz A, Schödel F, Hessel L; Hexavalent Vaccine Trial Study Group. Mallet E, et al. Among authors: stojanov s. Vaccine. 2004 Mar 29;22(11-12):1343-57. doi: 10.1016/j.vaccine.2003.09.039. Vaccine. 2004. PMID: 15063556 Review.
91 results